SCHEMBL19981490

SCHEMBL19981490

OC1CCCc2sc(S)cc21

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
UGT2B17 O75795 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13303498 0.78 UGT2B17 (0.47) UGT2B17
SCHEMBL13303619 0.74 UGT2B17 (0.40) UGT2B17
SCHEMBL11987809 0.74 KCNH2 (0.41) UGT2B17
SCHEMBL11987733 0.74 UGT2B17 (0.40) UGT2B17
SCHEMBL17970208 0.73 UGT2B17 (0.42) UGT2B17
SCHEMBL13330908 0.73 PNMT (0.42) UGT2B17
SCHEMBL13303598 0.73 PNMT (0.42) UGT2B17
SCHEMBL10513907 0.71 CA2 (0.56)
SCHEMBL11987806 0.69 KCNH2 (0.40) UGT2B17
SCHEMBL11987731 0.69 UGT2B17 (0.36) UGT2B17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365970-B1 PYRIDAZINONES AND THEIR USE AS BTK INHIBITORS GILEAD CONNECTICUT INC (US) 2018-03-21 EP disclosed